Amyloid‐Related Imaging Abnormalities in the <scp>DIAN‐TU</scp>‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease
Nelly Joseph‐Mathurin(Mallinckrodt (United States)), Richard J. Perrin(Washington University in St. Louis), Nicole S. McKay(Mallinckrodt (United States)), Serge Gauthier(Texas Instruments (France)), Clifford R. Jack(Mayo Clinic), Karen C. Holdridge(Eli Lilly (United States)), Hiroyuki Shimada(National Center for Geriatrics and Gerontology), Mathias Jucker(University of Basel), Nick C. Fox(NIHR Queen Square Dementia Biomedical Research Unit), Sarah Berman(University of Pittsburgh Medical Center), Anne M. Fagan(Washington University in St. Louis), David Wallon(Centre Hospitalier Universitaire de Rouen), Ivonne Z. Jiménez‐Velázquez(University of Puerto Rico System), Johannes Levin(The University of Melbourne), Carlos Cruchaga(Washington University in St. Louis), Sandra E. Black(Sunnybrook Health Science Centre), Austin McCullough(Mallinckrodt (United States)), William S. Brooks(UNSW Sydney), Bret Borowski(Mayo Clinic in Florida), Carsten Hofmann(Roche (Switzerland)), Ging‐Yuek Robin Hsiung(University of British Columbia), Jason Hassenstab(Washington University in St. Louis), Jakub Wojtowicz(Roche (Switzerland)), Roger Clarnette(The University of Western Australia), Eric McDade(University of Pittsburgh), Catherine J. Mummery(University College London), Martin R. Farlow(MRC Laboratory of Molecular Biology), Diana A. Hobbs(Mallinckrodt (United States)), Guoqiao Wang(Washington University in St. Louis), Shaney Flores(Mallinckrodt (United States)), Michele Mancini(Bank of Italy), Gregory M. Preboske(Mayo Clinic in Arizona), Mario Masellis(Sunnybrook Health Science Centre), Charles D. Chen(Massachusetts General Hospital), John M. Ringman(University of California, Los Angeles), Jasmeer P. Chhatwal(Harvard University), Kazushi Suzuki(National Defense Medical College), Russ C. Hornbeck(Mallinckrodt (United States)), Brian A. Gordon(Mallinckrodt (United States)), Jorge J. Llibre‐Guerra(Washington University in St. Louis), Ethan Park(Washington University in St. Louis), Yan Li(Washington University in St. Louis), Qīng Wáng(Beijing Technology and Business University), Gregory Klein(Roche (Switzerland)), R. Yaari(Eli Lilly (United States)), B. Joy Snider(Washington University in St. Louis), Thomas D. Bird(University of Washington), Neelum T. Aggarwal(Rush University Medical Center), Chengjie Xiong(Guangzhou Institutes of Biomedicine and Health), Lawrence S. Honig(Columbia University)
Cited by 42
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k